Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

SUMATRIPTAN SUCCINATE

Active
SPE2DP-26-T-4238Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

5250 GIBSON AVE BLDG 5250, JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4238.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
SUMATRIPTAN SUCCINATE TABLETS
SUMATRIPTAN SUCCINA
SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9 TABLETS. STORE AT 20
TO 25 C (68 TO 77 F). [SEE USP CONTROLLED ROOM TEMPERATURE.]PROTECT
FROM LIGHT. INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR
WITHOUT AURA IN ADULTS.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-5632-59 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0013-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4238
SECTION B
PR: 7017577631 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017577631 0001 BT 1.000
NSN/MATERIAL:6505017278704
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5000
FM5000 673 MDSS SGSM
5250 GIBSON AVE BLDG 5250
JBER AK 99506-4400
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FM5000
FM5000 673 MDSS SGSM
CP 907 552 8846
5250 GIBSON AVE BLDG 5250
JBER AK 99506
US
M/F: (TCN) FM500062010440
RDD:
PROJ: TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
SPE2DP-26-T-4238
SECTION B
PR: 7017577631 PRLI: 0001 CONT’D
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/24/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017577605 0001 BT 5.000
NSN/MATERIAL:6505017278704
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PKGING DATA MIL-STD-2073-1E QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z UNIT CONT:ZZ OPI:M INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ PACK CODE:Z PACKING LEVEL: B MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129. SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a
SPE2DP-26-T-4238
SECTION B
PR: 7017577605 PRLI: 0001 CONT’D
shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5000
FM5000 673 MDSS SGSM
5250 GIBSON AVE BLDG 5250
JBER AK 99506-4400
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FM5000
FM5000 673 MDSS SGSM
CP 907 552 8846
5250 GIBSON AVE BLDG 5250
JBER AK 99506
US
M/F: (TCN) FM500062010583
RDD:
PROJ: TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/24/2026
SPE2DP-26-T-4238 NSN/Part Number: 6505-01-727-8704 Quantity: 1 BT Purchase Request: 7017577631QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC MThe contract is for Psyllium Hydrophilic Mucilloid in sugar orange flavor, supplied in 12 gm packets, with each packet containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per box. The item is regulated by the FDA and must be procured with the specified manufacturer part number NDC37000-0740-87 from The Procter & Gamble Distributing LLC. It carries a non-extendable 24-month shelf life under Type I (Code M) requirements and must be packaged and marked in strict accordance with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet DLA requirements, including commercial-grade sealed unit containers and shipping containers that ensure safe delivery at the lowest possible rate. The unit of issue is a package of 30s, with a total quantity of 4 packages required. Delivery is FOB destination within 20 days, with zero variance permitted, and inspection and acceptance occur at the delivery point. The shipment is designated for a military vessel, with specific transportation protocols requiring the use of traceable methods and prohibiting parcel post. All labeling, packing, and marking must comply with applicable DLA standards, and bidders must clearly state the source and part number. The contract is issued under solicitation SPE2DP-26-T-4220 with an original delivery deadline of July 23, 2026, and is managed by the Department of Defense’s Medical Supply Chain PHARM FSA.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORIDVerapamil hydrochloride injection is a 5 mg per 2 mL (2.5 mg/mL) preservative-free, single-dose solution supplied in 2 mL glass flip-top vials, with a package quantity of 25 vials per unit. The product is intended solely for intravenous use and must be protected from light during storage and handling. It should be stored at a controlled room temperature of 20 to 25°C (68 to 77°F) in accordance with USP standards. The item has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The NSN is 6505-01-738-0226, and the purchase request number is 7017548722 with a delivery requirement of five days after order award. The contract is issued under solicitation number SPE2DP-26-T-4217, posted on July 21, 2026, with a response deadline of July 27, 2026. The NAICS code is 325411, and the contracting agency is the Department of Defense through the Medical Supply Chain Pharmaceutical FSA. Delivery is to Joint Base Elmendorf-Richardson in Alaska, 99506-4400. The contract incorporates technical and quality requirements from the DLA Master List and applies DLA packaging standards. Covered defense information may apply, and federal regulations require removal of government identification from non-accepted supplies. Primary point of contact is Daniel Porter, reachable by phone or email as listed.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets, 100 mg, in bottles of nine tablets, are procured for the acute treatment of migraine with or without aura in adults, with storage requirements between 20 to 25°C (68 to 77°F) and protection from light. The product has a non-extendable 24-month shelf life as a Type I (Code M) item and must be marked in compliance with the latest Medical Marking Standard No. 1 and MIL-STD-129, with packaging governed by MIL-STD-2073-1E and DLA’s Packaging Requirements for Procurement. Two delivery lines are specified: one for two bottles to Fort Stewart, Georgia, and another for one bottle to Joint Base Elmendorf-Richardson, Alaska, both with a five-day delivery window and FOB destination terms, zero quantity variance, and inspection and acceptance occurring at the delivery point. The item is regulated by the FDA, and bidders must provide manufacturer details, including NDC numbers for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., along with required documentation referenced from the DLA Master List of Technical and Quality Requirements. The solicitation, issued under SPE2DP-26-T-4216 by the Department of Defense, requires shipment via traceable means only, prohibits parcel post, and includes federal-specific codes for distribution, tracking, and government use. The original required delivery dates are July 22 and July 23, 2026, with the solicitation closing on July 27, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
SODIUM CHLORIDE INJECTSodium Chloride Injection is a sterile, nonpyrogenic intravenous solution designated for fluid and electrolyte replenishment, serving as a source of water and essential electrolytes. It contains no antimicrobial agents and is supplied in single-dose containers, intended for medical use under strict aseptic conditions. The product must comply with stringent packaging and marking requirements per Medical Marking Standard No. 1, superseding MIL-STD-129, and must be labeled in accordance with SPE2DP-26-T-4198. Each unit must be sealed in protective packaging to prevent damage or breakage and packed in commercial shipping containers suitable for safe transport at the lowest carrier rate to the delivery point. The product must be stored in moisture barrier overwrap at room temperature (25°C/77°F), avoiding excessive heat, and must maintain a shelf life of 15 months with no more than two months elapsed between manufacture and government delivery. It is manufactured by Baxter Healthcare Corporation under part number 2B1313Q and identified by NSN 6505014622120, with a unit of issue of PG. The contract specifies a single unit quantity of one PG to be delivered within 20 days FOB destination, with zero variance permitted in quantity and inspection and acceptance occurring at the point of delivery. The solicitation under number SPE2DP-26-T-4198, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, requires compliance with the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition size. The product must be procured under the DoD authorized unit of issue, referenced via official DLA documentation. All documentation, including marking and packaging, must strictly adhere to current DLA standards, and technical specifications are incorporated by reference. The point of contact is Meghan Smink, with the place of performance identified as Sea Girt, NJ, 08750-0000, and the response deadline for bids closing in July 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
SKIN PROTECTIVE OINThe contract specifies the procurement of 3M CAVILON DURABLE BARRIER CREAM 3355, a concentrated, pH-balanced, waterproof skin protective ointment formulated with 3M polymer technology to resist wash-off and enhance adhesive adherence while moisturizing skin and safeguarding against bodily fluids. Each unit is a 3.25-ounce (92 g) tube, sold in a case of twelve, and must be stored at room temperature between 68°F and 77°F (20°C to 25°C), with temporary excursions allowed between 59°F and 86°F (15°C to 30°C). The product has a non-extendable shelf life of 24 months under the RS016 requirement for a Type I code M item. The specification incorporates technical and quality standards from the DLA Master List of Technical and Quality Requirements, with compliance tied to the master list revision effective on the solicitation or award date. Packaging must meet DLA procurement standards, and government identification must be removed from non-accepted supplies. Covered defense information may apply, and bidders are required to clearly state the source and part number being supplied. The NSN is 6505-01-727-6854, with a single case order quantity under purchase request 7017546881, and delivery is required within 20 days of order award. The solicitation, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of July 27, 2026, and is cataloged under NAICS code 325411 with performance at Nellis AFB, Nevada.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
DOCOSANOL CREAMThe contract solicitation SPE2DP-26-T-4191 is for the procurement of DOCOSANOL CREAM 10% in 2g tubes, an FDA-regulated topical treatment for herpes simplex virus type 1 (HSV-1), commonly used to shorten healing time and soothe symptoms of cold sores or fever blisters on the face or lips for adults and children 12 years of age and older. The product must be stored between 20°C and 25°C (68°F to 77°F) and must not be frozen, with a non-extendable shelf life of 24 months classified as a TYPE I (CODE M) item. Deliveries are required to be made within 20 days of order receipt, with specified delivery dates ranging from April to May 2026, and are to be delivered FOB destination to multiple U.S. military installations including Fort Carson, Colorado and Fort Bragg, North Carolina. The entire order consists of 28,000 tubes distributed across five contract line item numbers (CLINs), with each CLIN specifying precise bulk break points and delivery addresses for government receipt. All items must be packaged in accordance with MIL-STD-2073-1E using commercial-grade methods that ensure protection against damage during transit, and must be palletized per DLA Packaging Requirements (RP001). Marking must strictly follow Medical Marking Standard No. 1, which supersedes MIL-STD-129 for all medical acquisitions, and includes barcode and labeling requirements accessible through DLA Troop Support. Shipment must be traceable through common carriers—parcel post is prohibited—and invoicing must be processed via the Wide Area WorkFlow system. The item is regulated under the FDA, and contractors must comply with applicable FAR and DFARS clauses, including cybersecurity safeguards (252.204-7012), prohibitions on restricted telecommunications equipment (252.204-7018), requirements for whistleblower protections (252.203-7002), and ethical restrictions on former DoD officials. Offerors must provide a Unique Entity Identifier and CAGE code, affirm size status and socioeconomic certifications where applicable, and comply with all representation and certification requirements in Section K. Technical and quality requirements referenced by R, I, or other identifiers are governed by the DLA Master List of Technical and Quality Requirements, and any
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 5 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.
Pharmaceutical Preparation Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
MULTIPLE ELECTROLYTThe contract specifies the procurement of Multiple Electrolytes Injection, Type 1, USP, in 500 mL bags, packaged in units of 24 per package, with a required shelf life of 18 months. No more than three months may have elapsed between the date of manufacture and the date of delivery to the government. The product is regulated by the FDA and must meet all applicable technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, with packaging and marking strictly compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, low-cost delivery to the point of delivery at Fort Bliss, Texas, with inspection and acceptance occurring at the destination. The item is identified by NSN 6505-01-462-5414 and manufacturer part number NDC00338-0221-03, produced by Baxter Healthcare Corp. The contract requires delivery within 20 days under FOB destination terms with zero variance allowed in quantity. The solicitation is issued under SPE2DP-26-T-4243 with a response deadline in July 2026, and the unit of issue is PG (package of 24), aligned to the DoD authorized unit. Additional provisions include handling of covered defense information and compliance with DLA’s packaging and labeling standards for medical acquisitions.
Pharmaceutical Preparation Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
FLUCONAZOLE TABLETSFluconazole Tablets 150 mg are supplied in individually sealed blister strips containing 12 tablets per strip, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible freight rate. All items must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the supply except under specific exceptions for functional components like batteries or instruments, which must meet additional containment and shockproof requirements. The National Stock Number is 6505013953039, and the contract is issued under solicitation SPE2DP-26-T-4241 with delivery required FOB destination within 20 days. The quantity ordered is one package with zero variance allowed, and inspection and acceptance occur at the delivery point. The manufacturer identified is Golden State Medical Supply, Inc. with NDC 51407-0426-12, and ANIP Acquisition Co with NDC 62559-0992-12. Applicable technical and quality requirements are referenced from the DLA Master List, and the contract falls under the NAICS code 325412 for pharmaceutical manufacturing.
Pharmaceutical Preparation Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.
Pharmaceutical Preparation Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details